Adaptimmune Therapeutics
Adaptimmune Therapeutics
World Rank (Jan-05-2024)
17,897
Market Cap (Jan-05-2024)
0.200 Billion USD
World Rank (Jul-30-2023)
18,058
Market Cap (Jul-30-2023)
0.200 Billion USD
World Rank (Jan-07-2022)
12,831
Market Cap (Jan-07-2022)
0.548 Billion USD
World Rank (Jan-01-2021)
8,730
Market Cap (Jan-01-2021)
0.834 Billion USD
Headquarters Country
Nasdaq / NYSE Code
ADAP
World Region
World Subregion
Annual Revenue in USD
7 Million USD
Annual Net Income in USD
-186 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Total Assets in USD
552 Million USD
Total Liabilities in USD
310 Million USD
Total Equity in USD
241 Million USD
Balance Sheet for Period Ending
Dec-2021 ending year
Business Sector
Company Website
Yahoo
Ads